(Q51469568)

5 April 2018

title

Serum lipid level in Iranian patients with psoriasis. (English)

1 reference

5 April 2018

author

Hossein Mahjub

5

1 reference

5 April 2018

author name string

Farshchian M

1

1 reference

5 April 2018

Zamanian A

2

1 reference

5 April 2018

Farshchian M

3

1 reference

5 April 2018

Monsef AR

4

1 reference

5 April 2018

publication date

1 July 2007

1 reference

5 April 2018

Journal of the European Academy of Dermatology and Venereology

published in

1 reference

5 April 2018

volume

21

1 reference

5 April 2018

issue

6

1 reference

5 April 2018

page(s)

802-805

1 reference

5 April 2018

Recent developments in the understanding of the pathogenesis of psoriasis.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.02099.X

Increased risk for cardiovascular mortality in psoriasis inpatients but not in outpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.02099.X

Evaluation of the atherogenic tendency of lipids and lipoprotein content and their relationships with oxidant-antioxidant system in patients with psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.02099.X

Disease concomitance in psoriasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.02099.X

The inflammatory response in mild and in severe psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.02099.X

C-reactive protein and alpha2-macroglobulin plasma activity in medium-severe and severe psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.02099.X

Acitretin in psoriasis: an overview of adverse effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.02099.X

Lipids and CVD management: towards a global consensus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.02099.X

Dislipidemia and oxidative stress in mild and in severe psoriasis as a risk for cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.02099.X

Serum lipids and apolipoproteins in patients with psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.02099.X

Lipid profile, insulin secretion, and insulin sensitivity in psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.02099.X

The variation of serum lipoprotein (a) level with disease activity in psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.02099.X

Psoriasis and occlusive vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.02099.X

10.1111/J.1468-3083.2006.02099.X

21 January 2018

Identifiers

DOI

1 reference

5 April 2018

1 reference

5 April 2018